NeuroMetrix, Inc. is a medical device company focused on the treatment of the neurological complications of diabetes. The Company managed its general purpose neurodiagnostic business to improve reimbursement and minimize customer erosion. The Company’s tools and therapies for addressing diabetic neuropathy represent a significant market opportunity. It’s both unique and substantial experience in devices to measure and alter peripheral nerve function, it addresses unmet needs through the development of proprietary medical devices. The Company intends to advance its objectives in the diabetic neuropathy market which include: Driving Commercial Adoption of its Proprietary Products for Diabetic Neuropathy in the United States. The Company’s two primary products that target the diabetic neuropathy market are: SENSUS and NC-stat DPNCheck. SENSUS is therapeutic device for relief of chronic, intractable pain. NC-stat DPNCheck, is a diagnostic test for Diabetic Peripheral Neuropathy or DPN.